Search
Lyra Therapeutics Inc
LYRAAdd to Watchlist
0.495USD
0.0000.00%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
1.01MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-03-16The current earnings forecast score of Lyra Therapeutics Inc is 6.00, ranking 342 out of 393 in the Biotechnology & Medical Research industry. The average price target is 23.00, with a high of 30.00 and a low of 16.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Lyra Therapeutics Inc's price target?
Analysts forecast that Lyra Therapeutics Inc's price target is USD 23.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 16.00.
How have Lyra Therapeutics IncLYRA's recent earnings per share performed?
The market expectation was USD -3.91, while Lyra Therapeutics IncLYRA's earnings per share (EPS) for the previous quarter was USD -3.38. EPS for the next quarter is expected at USD -1.36.
